Evaluation of Novel Targets for Retinal Ganglion Cell Axon Regeneration
Evaluation of Novel Targets for Retinal Ganglion Cell Axon Regeneration
批准号:
9205998
负责人:
STEPHEN M STRITTMATTER
金额:
$68.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2019-08-31
关键词:
AdultAffectAxonAxotomyBioinformaticsBiological AssayBiological Neural NetworksBrainCaenorhabditis elegansCellsCerebral cortexClustered Regularly Interspaced Short Palindromic RepeatsCoupledDataData SetEvaluationGene CombinationsGenesGenetic ScreeningGenetic TranscriptionGenetic screening methodGenomeGenomic DNAGoalsGrowthHumanInjuryLateral Geniculate BodyLightMammalsMessenger RNAMethodsMicroscopyMonitorMotorMusNational Eye InstituteNatural regenerationNematodaNervous system structureNeuraxisNeuronsOptic NerveOrganismPathway interactionsPatientsPeripheral Nervous SystemPhenotypeProcessPublishingRecoveryRetinaRetinalRetinal Ganglion CellsRoleSpecificitySpinal CordSystemTestingTransgenesVisionVisual system structureaxon growthaxon guidanceaxon regenerationaxonal pathfindingaxonal sproutingbasebrain tissuecell typecentral nervous system injurygene discoverygene functiongenome-widein vivoknock-downloss of functionnoveloptic nerve regenerationreconstitutionrelating to nervous systemrepairedresearch studyresponserestorationscreeningsmall hairpin RNAsynaptogenesistranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
The National Eye Institute has identified the restoration of vision as an “audacious goal” requiring the
reestablishment of neural connections from a functional retina with the brain. Unfortunately, the regeneration of
adult mammalian CNS axons is extremely limited or nil. The reconnection of retinal ganglion cells with lateral
geniculate neurons to support vision recovery requires overcoming endogenous limitations on axonal
regeneration. A small group of genes limiting regeneration in particular retinal ganglion cell subtypes have
been identified, but only a very small fraction of the genome has been tested with regard to a role in limiting
axon regeneration. We hypothesize that additional regeneration-regulating factors exist, and that conservation
of function across cell types, species and modes of growth will facilitate their discovery.
We have completed a genome-wide shRNA-based screen for endogenous genes limiting the repair of axons in
the mammalian CNS using cultured mouse cerebral cortex neurons with over 135,000 separate regeneration
experiments. Across 17,000 genes, this loss of function screen yielded 500 regeneration genes. Here, our
primary goal is to test this selected list for the ability to promote retinal ganglion cell axon regeneration in vivo.
We expect that genes with the most robust regeneration-limiting function will have conserved function from
cortical neurons to retinal ganglion cells. Amongst the cortical axon regeneration gene list, we will prioritize
genes for optic nerve regeneration experiments using two additional datasets. In one experiment, we
determined the distinct transcriptional profiles of sprouting versus non-sprouting mouse CST neurons after
CNS injury, hypothesizing that the most relevant genes will participate in both sprouting and regeneration, as is
the case for previously described regeneration factors. We have also conducted experiments to identify
species conservation of regeneration by screening for genes that regulate motor axon regeneration in the
nematode C. elegans. Factors common to multiple experimental systems are expected to identify fundamental
mechanisms in regeneration that are likely to affect the equivalent process in human visual system.
For those newly discovered genes whose loss of function supports optic nerve regeneration, secondary studies
will assess synergy amongst positive genes, retinal ganglion cell type specificity of action, and central axonal
pathfinding function. This project builds on genetic screens in the mature mouse central nervous system and C.
elegans to analyze novel mechanisms that promote axon regeneration after mammalian retinal ganglion cell
axotomy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:9921655
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2020
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Administrative Core
-
批准号:10180852
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2020
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Administrative Core
-
批准号:10620813
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2020
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Administrative Core
-
批准号:10431895
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2020
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Yale Alzheimer Disease Research Center
-
批准号:10620812
-
项目类别:
-
资助金额:$318.24万
-
财政年份:2020
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Yale Alzheimer Disease Research Center
-
批准号:10180851
-
项目类别:
-
资助金额:$320.33万
-
财政年份:2020
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Yale Alzheimer Disease Research Center
-
批准号:10431894
-
项目类别:
-
资助金额:$319.31万
-
财政年份:2020
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Yale Alzheimer Disease Research Center
-
批准号:9921654
-
项目类别:
-
资助金额:$320.6万
-
财政年份:2020
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP
-
批准号:10221595
-
项目类别:
-
资助金额:$77.53万
-
财政年份:2019
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP
-
批准号:10434043
-
项目类别:
-
资助金额:$77.53万
-
财政年份:2019
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP
-
批准号:10642722
-
项目类别:
-
资助金额:$77.53万
-
财政年份:2019
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP
-
批准号:10018666
-
项目类别:
-
资助金额:$77.53万
-
财政年份:2019
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease
-
批准号:10358931
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2018
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease
-
批准号:10459336
-
项目类别:
-
资助金额:$165.7万
-
财政年份:2018
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease
-
批准号:9763413
-
项目类别:
-
资助金额:$165.79万
-
财政年份:2018
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease
-
批准号:10231162
-
项目类别:
-
资助金额:$166.73万
-
财政年份:2018
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Genome-Wide Discovery and Translational Research for Neural Repair
-
批准号:10528486
-
项目类别:
-
资助金额:$104.48万
-
财政年份:2016
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Genome-Wide Discovery and Translational Research for Neural Repair
-
批准号:9392594
-
项目类别:
-
资助金额:$101.57万
-
财政年份:2016
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Genome-Wide Discovery and Translational Research for Neural Repair
-
批准号:10322446
-
项目类别:
-
资助金额:$104.48万
-
财政年份:2016
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
Characterizing and Targeting Pyk2 Kinase in Alzheimer’s Disease
-
批准号:9196005
-
项目类别:
-
资助金额:$209.01万
-
财政年份:2016
-
负责人:STEPHEN M STRITTMATTER
-
依托单位:
海外基金